Investor Overview Press Releases April 30, 2024 Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update February 27, 2024 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update January 16, 2024 Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review View all » Events May 7, 20245:00 PM EDT Aclaris Therapeutics First Quarter 2024 Conference Call Nov 13, 20238:00 AM EST Aclaris Therapeutics Call to Discuss Zunsemetinib Phase 2b Rheumatoid Arthritis Trial Results Sep 26, 202310:30 AM EDT Aclaris Therapeutics at 2023 Cantor Global Healthcare Conference View all » Feature Presentation Aclaris Therapeutics Company Overview – November 2023
April 30, 2024 Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
February 27, 2024 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Nov 13, 20238:00 AM EST Aclaris Therapeutics Call to Discuss Zunsemetinib Phase 2b Rheumatoid Arthritis Trial Results